Femoral frACturEs and COVID-19.

Femoral frACturEs and COVID-19. Retrospective Comparative Cohort Study on the Early Prognosis of Patients Affected by Proximal Femur Fractures and COVID-19.

Status

UNKNOWN

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT04657510

Acronym

FACE COVID-19

Enrollment

140

Registered

2020-12-08

Start date

2020-11-14

Completion date

2020-12-31

Last updated

2020-12-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Covid19, Femur Fracture, Fragility Fracture

Keywords

proximal femur fracture, fragility fracture, Covid-19, SARS-CoV2, FACE-COVID 19, prognosis, cohort study

Brief summary

Retrospective cohort study comparing the early prognosis after surgically-treated proximal femur fragility fractures in patients affected and not affected by COVID-19.

Interventions

OTHERCOVID-19

Patients affected versus not affected by COVID-19, with the same starting condition (proximal femur fracture)

Study design

Observational model

COHORT

Time perspective

RETROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

45 Years to No maximum

Healthy volunteers

Inclusion criteria

* Age ≥45 years * Admitted to IRCCS Orthopaedic Institute Galeazzi for proximal femur fractures from march 2020 to april 2020. * Tested for COVID-19 through naso-pharyngeal swab analized with RT-PCR

Exclusion criteria

* Age \<45 years * Not tested for SARS-CoV-2 * Other fractures (including bilateral proximal femur fractures)

Design outcomes

Primary

Measure	Time frame	Description
Survival at discharge day (comparison between the two groups)	on discharge day, on average after 1 week	Survival at discharge day (comparison between the two groups)

Secondary

Measure	Time frame	Description
Length of stay (comparison between the two groups)	on discharge day, on average 1 week	Length of stay (comparison between the two groups)
Readmission rate (comparison between the two groups)	up to 30 days after discharge	Readmission rate (comparison between the two groups)
Complications rate (comparison between the two groups)	up to 30 days after discharge	Complications rate (comparison between the two groups)
Survival at 30 days after discharge (comparison between the two groups)	30 days after discharge	Survival at 30 days after discharge (comparison between the two groups)
Routine lab exams values (comparison between the two groups)	At admission, 1st postoperative day, 5th postoperative day, on discharge day	Routine lab exams values (comparison between the two groups)

Countries

Italy

Contacts

Primary ContactGiuseppe M Peretti, MD

giuseppe.peretti@unimi.it0039 3396610282

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026